MedTrace Logo

DePuy Revision TKA Implant 5yr Survivorship

NCT01245478 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-05-01

No results posted yet for this study

Summary

This will be a retrospective chart review of 200 charts of adult patients who have undergone a revision TKA at New England Baptist Hospital and who received implant component(s) manufactured by DePuy Orthopedics. The data will be collected retrospectively after patients are seen clinically for a minimum of five years after surgery to answer:

1. What is the five-year survivorship of revision a knee prosthesis containing components manufactured by DePuy Orthopedics among adult revision TKA patients?
2. What patient factors are associated with the need for re-operation after revision TKA among patients receiving DePuy implant components? How do clinical outcomes change from baseline over the five-year follow-up after revision TKA surgery?

Data collection will include patient-reported and clinician-reported measures.

Conditions

  • Complications; Arthroplasty, Mechanical

Sponsors & Collaborators

  • Depuy, Inc.

    collaborator INDUSTRY

  • The New England Baptist Hospital

    lead OTHER

Principal Investigators

  • John Richmond, MD · New England Baptist Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-07-31
Completion
2012-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245478 on ClinicalTrials.gov